Humoon is experienced in supporting pharmaceutical companies navigate the complex UK medicines commissioning landscape, including preparations for health technology assessments (HTAs) and engagement with NHS England commissioning teams. He has supported multiple NICE appraisals, including company preparations for committee meetings and appeals. Humoon holds a Master’s degree in Drug Discovery and Pharma Management from University College London.
